Top Markets
#1 Black Phoenix Black Phoenix +734.39%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.97%
#3 MetaDAO MetaDAO +22.54%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +18.17%
#5 Verus Coin Verus Coin +14.03%
#6 Akedo Akedo +8.97%
#7 Biconomy Biconomy +8.23%
#8 Tokamak Network Tokamak Network +7.07%
#9 XYO Network XYO Network +6.81%
#10 Tornado Cash Tornado Cash +5.67%
Coin of the day
Black Phoenix Black Phoenix
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Pacific Edge Limited Pacific Edge Limited

Pacific Edge Limited

PEB
Hisse Senetlerindeki Sıralama #18768
Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001,... Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001, operates as a cancer diagnostics firm. The company's core mission involves the research, development, and commercialization of advanced diagnostic and prognostic tools aimed at the early identification and ongoing management of various cancers. Its diagnostic solutions are accessible in New Zealand, the United States, Australia, and Singapore, with operations structured across Commercial and Research segments. A key offering is the Cxbladder suite, a collection of genomic urine tests specifically designed for detecting and managing bladder cancer. Within this suite, Cxbladder Resolve aids in identifying patients likely to present with more aggressive or advanced bladder cancer. Cxbladder Triage helps pinpoint individuals with haematuria who exhibit a low probability of bladder cancer, while Cxbladder Detect offers a non-invasive method for identifying bladder and other urinary tract cancers. Furthermore, Cxbladder Monitor facilitates continuous surveillance for disease recurrence in bladder cancer patients. Beyond its focus on bladder cancer, Pacific Edge is actively developing additional diagnostic innovations. These include Cxcolorectal, a prognostic gene signature for assessing outcomes in patients diagnosed with stage II or stage III colorectal cancers, alongside pipeline products targeting gastric, endometrial cancers, and melanoma.
Hisse Fiyatı
$0.15059107
Piyasa Değeri
$187.01M
Değişim (1 gün)
-1.96%
Değişim (1 yıl)
83.59%
Ülke
NZ
Ticaret Pacific Edge Limited (PEB)

Kategori

Healthcare
Pacific Edge Limited (PEB) için temettü geçmişi
Pacific Edge Limited (hisse sembolü: PEB) toplam 0 temettü ödemesi yaptı.
Tüm temettülerin toplamı (hisse bölünmeleriyle ayarlanmış): 0.00
Temettü verimi (TTM): 0
Pacific Edge Limited (PEB) için 2026 ile 2026 arasındaki temettü ödemeleri
Yıllık temettü ödemeleri
Yıl Temettü (hisse bölünmesiyle ayarlanmış) Değiştir
Sağlanan tarihler için yeterli veri yok.
Tüm temettü ödemelerinin listesi
Yıl Temettü Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için temettü ödemeleri
Şirket Temettü ödemesi sayısı Ülke
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
60.00%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
134.00%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
0.00%
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
0.00%
US
Agilent Technologies, Inc. Agilent Technologies, Inc.
Agilent Technologies, Inc.
A.US
58.00%
US